Yu-Tzu Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yu-Tzu Chang has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
Chien-Yao Sun
7 shared publicationsJia-Ling Wu
6 shared publications- Chung-Yi Li
Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan
4 shared publications Chi-Chang Shieh
3 shared publicationsChiao-Hsuan Chao
3 shared publications- Chien-Yao Sun
Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
3 shared publications
Latest Publications
- 2 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Real‐World Comparison of Cardiorenal Outcomes With SGLT ‐2 Inhibitors Versus GLP ‐1 Receptor Agonists in Type 2 Diabetes
Aims: To compare cardiorenal outcomes, mortality and safety between sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) in adults with Type 2 diabetes (T2D). Materials and Methods: We conducted a retrospective, new‐user cohort study using the TriNetX global federated health research network. We identified 249 237 propensity score‐matched pairs (498 474 total patients) who initiated SGLT‐2i or GLP‐1 RA between 2018 and 2023. The primary outcome was a kidney failure/death composite, defined as kidney failure, dialysis, kidney transplantation or all‐cause mortality. Secondary outcomes included composite cardiovascular events, mortality and safety profiles. Results: SGLT‐2i initiation was associated with a lower risk of the kidney failure/death composite compared with GLP‐1 RA (HR: 0.87, 95% CI: 0.85–0.89). For the kidney‐specific component, SGLT‐2i initiation was associated with a lower risk of kidney failure, dialysis or kidney transplantation (HR: 0.74, 95% CI: 0.71–0.78), while all‐cause mortality was also lower (HR: 0.90, 95% CI: 0.88–0.93). The composite cardiovascular outcome (myocardial infarction, stroke, acute heart failure, cardiogenic shock, cardiac arrest or death) was broadly comparable between groups (HR: 0.98, 95% CI: 0.97–1.00). Conclusions: SGLT‐2i initiation was associated with lower risks of kidney failure‐related outcomes and all‐cause mortality compared with GLP‐1 RA initiation, while cardiovascular outcomes were broadly comparable. These findings may inform individualized treatment selection in adults with T2D.
- 2 November 2026
- Published by Wiley in Diabetes, Obesity and Metabolism
Real‐World Comparison of Cardiorenal Outcomes With SGLT ‐2 Inhibitors Versus GLP ‐1 Receptor Agonists in Type 2 Diabetes
Aims: To compare cardiorenal outcomes, mortality and safety between sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) in adults with Type 2 diabetes (T2D). Materials and Methods: We conducted a retrospective, new‐user cohort study using the TriNetX global federated health research network. We identified 249 237 propensity score‐matched pairs (498 474 total patients) who initiated SGLT‐2i or GLP‐1 RA between 2018 and 2023. The primary outcome was a kidney failure/death composite, defined as kidney failure, dialysis, kidney transplantation or all‐cause mortality. Secondary outcomes included composite cardiovascular events, mortality and safety profiles. Results: SGLT‐2i initiation was associated with a lower risk of the kidney failure/death composite compared with GLP‐1 RA (HR: 0.87, 95% CI: 0.85–0.89). For the kidney‐specific component, SGLT‐2i initiation was associated with a lower risk of kidney failure, dialysis or kidney transplantation (HR: 0.74, 95% CI: 0.71–0.78), while all‐cause mortality was also lower (HR: 0.90, 95% CI: 0.88–0.93). The composite cardiovascular outcome (myocardial infarction, stroke, acute heart failure, cardiogenic shock, cardiac arrest or death) was broadly comparable between groups (HR: 0.98, 95% CI: 0.97–1.00). Conclusions: SGLT‐2i initiation was associated with lower risks of kidney failure‐related outcomes and all‐cause mortality compared with GLP‐1 RA initiation, while cardiovascular outcomes were broadly comparable. These findings may inform individualized treatment selection in adults with T2D.
- Open Access
- 23 July 2026
- Published by Elsevier in Kidney Medicine
- Vol. 8 (10)
Humoral and Cellular Immune Responses Following Bivalent SARS-CoV-2 mRNA Vaccines in Patients Undergoing Hemodialysis: A Prospective Cohort Study
- 23 July 2026
- Published by Elsevier in Kidney Medicine
- Vol. 8 (10)
Open AccessHumoral and Cellular Immune Responses Following Bivalent SARS-CoV-2 mRNA Vaccines in Patients Undergoing Hemodialysis: A Prospective Cohort Study
- Open Access
- 15 April 2026
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 50 (2) , 105-116
Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
- 15 April 2026
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 50 (2) , 105-116
Open AccessEccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
- Open Access
- 27 August 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (2) , 212-220
Cellular and humoral immunity following two AZD1222 and two booster vaccinations in hemodialysis patients
- 27 August 2025
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 59 (2) , 212-220
Open AccessCellular and humoral immunity following two AZD1222 and two booster vaccinations in hemodialysis patients
- 4 August 2025
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 41 (1) , 112-124
Association between exposure to air pollution and kidney function decline
Background and hypothesis: Chronic kidney disease is a major global health concern, with air pollution increasingly recognized as a key contributor to kidney function decline. This study hypothesizes that exposure to air pollution accelerates kidney function decline, measured by ≥30% or ≥40% reductions in estimated glomerular filtration rate (eGFR). Methods: A nested case-control design was employed using data from the Adult Preventive Healthcare Services database and National Health Insurance claims (2016–2021). The study cohort comprised 871 295 health checkup participants. Cases were defined as participants with an eGFR decline of ≥30% or ≥40% from baseline, matched 1:1 with controls by time density sampling on sex, age, baseline eGFR, and follow-up duration. Air pollution exposure to six pollutants (PM2.5, PM10, NO2, SO2, CO, and O3) was assessed for the 1-, 2-, 3-, and 5-year period prior to the outcome occurrence using land-use regression combined with machine learning algorithms. Multivariate conditional logistic regression models were used to estimate odds ratios (ORs) for eGFR decline per interquartile range (IQR) increase in pollutant concentrations. Results: The study included 61 239 cases with eGFR declines ≥30% and 23 330 cases with declines ≥40%. Higher concentrations of all pollutants were associated with significant increases in odds for kidney function decline. CO and PM2.5 exhibited the strongest associations with eGFR decline. For an eGFR decline of ≥30%, an IQR increase in CO was associated with an aOR of 2.78 (95% confidence intervals (CI): 2.69–2.88), while PM2.5 showed an aOR of 2.60 (95% CI: 2.51–2.69). Similarly, for eGFR decline of ≥40%, CO had an aOR of 2.46 (95% CI: 2.33–2.60) and PM2.5 an aOR of 2.35 (95% CI: 2.23–2.48). Compared to 3- and 5-year exposure periods, the associations were strongest in the 1- and 2-year periods. Conclusion: Air pollution exposure accelerates kidney function decline, necessitating public health action.
- 4 August 2025
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 41 (1) , 112-124
Association between exposure to air pollution and kidney function decline
Background and hypothesis: Chronic kidney disease is a major global health concern, with air pollution increasingly recognized as a key contributor to kidney function decline. This study hypothesizes that exposure to air pollution accelerates kidney function decline, measured by ≥30% or ≥40% reductions in estimated glomerular filtration rate (eGFR). Methods: A nested case-control design was employed using data from the Adult Preventive Healthcare Services database and National Health Insurance claims (2016–2021). The study cohort comprised 871 295 health checkup participants. Cases were defined as participants with an eGFR decline of ≥30% or ≥40% from baseline, matched 1:1 with controls by time density sampling on sex, age, baseline eGFR, and follow-up duration. Air pollution exposure to six pollutants (PM2.5, PM10, NO2, SO2, CO, and O3) was assessed for the 1-, 2-, 3-, and 5-year period prior to the outcome occurrence using land-use regression combined with machine learning algorithms. Multivariate conditional logistic regression models were used to estimate odds ratios (ORs) for eGFR decline per interquartile range (IQR) increase in pollutant concentrations. Results: The study included 61 239 cases with eGFR declines ≥30% and 23 330 cases with declines ≥40%. Higher concentrations of all pollutants were associated with significant increases in odds for kidney function decline. CO and PM2.5 exhibited the strongest associations with eGFR decline. For an eGFR decline of ≥30%, an IQR increase in CO was associated with an aOR of 2.78 (95% confidence intervals (CI): 2.69–2.88), while PM2.5 showed an aOR of 2.60 (95% CI: 2.51–2.69). Similarly, for eGFR decline of ≥40%, CO had an aOR of 2.46 (95% CI: 2.33–2.60) and PM2.5 an aOR of 2.35 (95% CI: 2.23–2.48). Compared to 3- and 5-year exposure periods, the associations were strongest in the 1- and 2-year periods. Conclusion: Air pollution exposure accelerates kidney function decline, necessitating public health action.
- Open Access
- 14 June 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (6) , e70246
Development of Machine‐Learning‐Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis
Background: Cognitive impairment is common but frequently undiagnosed in the dialysis population. We aimed to develop and validate a quick and accurate screening tool using machine‐learning‐based approaches in them.Methods: In this cross‐sectional observational study, we administered the Mini‐Mental State Examination (MMSE) and Cognitive Abilities Screening Instrument (CASI) in 508 hemodialysis patients and randomly divided them into a derivation set (70%) and a validation set (30%). Using three to five key items from MMSE and CASI as predictors, we developed six machine learning models, including Lasso, classification and regression tree (CART), random forest (RF), extreme gradient boosting, support vector machine (SVM), and artificial neural networks to identify those with a CASI score below the 20th percentile of age‐ and education‐matched norms in the derivation set. We then evaluated the predictive performance of these models in the validation set.Results: The derivation samples (n = 357) had a mean (SD) age of 64.13 (11.92) years and a mean education level of 8.76 (4.91) years. Around 40% of participants had a CASI score below the 20th percentile. Among all models, the RF model achieved the highest performance of prediction, with an accuracy of 0.94, an area under the curve (AUC) of 0.95, and an F1 score of 0.92 in the validation set. The other models, except for CART, performed equally well in terms of AUC.Conclusions: Our study demonstrates that using machine‐learning models, we can identify patients with impaired cognition with only several questions in CASI and MMSE within 5 min.
- 14 June 2025
- Published by Wiley in European Journal of Neurology
- Vol. 32 (6) , e70246
Open AccessDevelopment of Machine‐Learning‐Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis
Background: Cognitive impairment is common but frequently undiagnosed in the dialysis population. We aimed to develop and validate a quick and accurate screening tool using machine‐learning‐based approaches in them.Methods: In this cross‐sectional observational study, we administered the Mini‐Mental State Examination (MMSE) and Cognitive Abilities Screening Instrument (CASI) in 508 hemodialysis patients and randomly divided them into a derivation set (70%) and a validation set (30%). Using three to five key items from MMSE and CASI as predictors, we developed six machine learning models, including Lasso, classification and regression tree (CART), random forest (RF), extreme gradient boosting, support vector machine (SVM), and artificial neural networks to identify those with a CASI score below the 20th percentile of age‐ and education‐matched norms in the derivation set. We then evaluated the predictive performance of these models in the validation set.Results: The derivation samples (n = 357) had a mean (SD) age of 64.13 (11.92) years and a mean education level of 8.76 (4.91) years. Around 40% of participants had a CASI score below the 20th percentile. Among all models, the RF model achieved the highest performance of prediction, with an accuracy of 0.94, an area under the curve (AUC) of 0.95, and an F1 score of 0.92 in the validation set. The other models, except for CART, performed equally well in terms of AUC.Conclusions: Our study demonstrates that using machine‐learning models, we can identify patients with impaired cognition with only several questions in CASI and MMSE within 5 min.
- Open Access
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0344522
Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis
Patients with kidney failure have worse immune response following vaccination compared to general population, but few clinical studies have investigated immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccination in hemodialysis patients. Here, we showed two doses of AZD1222 vaccines lead to high seroconversion rate of anti-SARS-CoV-2 receptor-binding domain (RBD) antibodies, and more than 80% patients acquired neutralizing antibodies against ancestral virus and delta variant.
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0344522
Open AccessTrajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis
Patients with kidney failure have worse immune response following vaccination compared to general population, but few clinical studies have investigated immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccination in hemodialysis patients. Here, we showed two doses of AZD1222 vaccines lead to high seroconversion rate of anti-SARS-CoV-2 receptor-binding domain (RBD) antibodies, and more than 80% patients acquired neutralizing antibodies against ancestral virus and delta variant.
- Open Access
- 2 January 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Effect of dialysis modalities on risk of hospitalization for gastrointestinal bleeding
Dialysis patients are at risk of both thromboembolic and bleeding events, while thromboembolism prevention and treatment may confer a risk of major bleeding. Gastrointestinal (GI) bleeding is a great concern which can result in high subsequent mortality rates. Our object was to clarify whether hemodialysis (HD) and peritoneal dialysis (PD) confer different incidence of GI bleeding, and further assist individualized decision-making on dialysis modalities. We conducted a population-based retrospective cohort study which included all incident dialysis patients above 18 years old derived from the National Health Insurance database from 1998 to 2013 in Taiwan. 6296 matched pairs of HD and PD patients were identified. A propensity score matching method was used to minimize the selection bias. The adjusted hazard ratio for GI bleeding was 1.13 times higher in the HD group than in the PD group, and data from the unmatched cohort and the stratified analysis led to similar results. Among subgroup analysis, we found that the use of anticoagulants will induce a much higher incidence of GI bleeding in HD patients as compared to in PD patients. We concluded that PD is associated with a lower GI bleeding risk than HD, and is especially preferred when anticoagulation is needed.
- 2 January 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Open AccessEffect of dialysis modalities on risk of hospitalization for gastrointestinal bleeding
Dialysis patients are at risk of both thromboembolic and bleeding events, while thromboembolism prevention and treatment may confer a risk of major bleeding. Gastrointestinal (GI) bleeding is a great concern which can result in high subsequent mortality rates. Our object was to clarify whether hemodialysis (HD) and peritoneal dialysis (PD) confer different incidence of GI bleeding, and further assist individualized decision-making on dialysis modalities. We conducted a population-based retrospective cohort study which included all incident dialysis patients above 18 years old derived from the National Health Insurance database from 1998 to 2013 in Taiwan. 6296 matched pairs of HD and PD patients were identified. A propensity score matching method was used to minimize the selection bias. The adjusted hazard ratio for GI bleeding was 1.13 times higher in the HD group than in the PD group, and data from the unmatched cohort and the stratified analysis led to similar results. Among subgroup analysis, we found that the use of anticoagulants will induce a much higher incidence of GI bleeding in HD patients as compared to in PD patients. We concluded that PD is associated with a lower GI bleeding risk than HD, and is especially preferred when anticoagulation is needed.
- 1 October 2022
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 89 (4) , 373-375
Hyperosmolar Hyperglycemic Crisis After Burn Injury in a Patient With Advanced Amyotrophic Lateral Sclerosis
Metabolic disturbance in patients of amyotrophic lateral sclerosis is a rare presentation that might be related to disease progression and outcomes. Hypermetabolic status after major burn injury remains a critical issue in the modern medical care. Here, we present a rare case of a patient sporadic amyotrophic lateral sclerosis who suffered from minor burn injury (8% total body surface area), developing critical hyperosmolar hyperglycemic state during early hospitalization. Newly diagnosed diabetes is established and found related to the underlying disease of this patient. The accumulative metabolic alteration among vulnerable patients of amyotrophic lateral sclerosis and burn injury is noteworthy. Judicious monitoring of fluid and metabolic status helps to prevent the occurrence of acute hyperosmolar hyperglycemic state.
- 1 October 2022
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 89 (4) , 373-375
Hyperosmolar Hyperglycemic Crisis After Burn Injury in a Patient With Advanced Amyotrophic Lateral Sclerosis
Metabolic disturbance in patients of amyotrophic lateral sclerosis is a rare presentation that might be related to disease progression and outcomes. Hypermetabolic status after major burn injury remains a critical issue in the modern medical care. Here, we present a rare case of a patient sporadic amyotrophic lateral sclerosis who suffered from minor burn injury (8% total body surface area), developing critical hyperosmolar hyperglycemic state during early hospitalization. Newly diagnosed diabetes is established and found related to the underlying disease of this patient. The accumulative metabolic alteration among vulnerable patients of amyotrophic lateral sclerosis and burn injury is noteworthy. Judicious monitoring of fluid and metabolic status helps to prevent the occurrence of acute hyperosmolar hyperglycemic state.
- 1 January 2022
- Published by Elsevier in NeuroToxicology
- Vol. 88, 178-186
Comparisons of vesicular monoamine transporter type 2 signals in Parkinson's disease and parkinsonism secondary to carbon monoxide poisoning
- 1 January 2022
- Published by Elsevier in NeuroToxicology
- Vol. 88, 178-186
Comparisons of vesicular monoamine transporter type 2 signals in Parkinson's disease and parkinsonism secondary to carbon monoxide poisoning